tiprankstipranks
Atossa Therapeutics (ATOS)
NASDAQ:ATOS
US Market

Atossa Therapeutics (ATOS) Technical Analysis

Compare
2,297 Followers

Technical Sentiment

Overall Consensus
Neutral
8Bullish
6Neutral
8Bearish
Technical Analysis Consensus
Neutral
2Bullish
6Neutral
2Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Atossa Therapeutics’s (ATOS) Moving Averages Convergence Divergence (MACD) indicator is -0.03, suggesting Atossa Therapeutics is a Sell.
Atossa Therapeutics’s (ATOS) 20-Day exponential moving average is 0.85, while Atossa Therapeutics’s (ATOS) share price is $0.84, making it a Buy.
Atossa Therapeutics’s (ATOS) 50-Day exponential moving average is 0.95, while Atossa Therapeutics’s (ATOS) share price is $0.84, making it a Sell.

Atossa Therapeutics (ATOS) Pivot Points

Feb 22, 2025, 12:36 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.79
0.81
0.82
0.84
0.86
0.88
0.89
Fibonacci
0.81
0.82
0.83
0.84
0.86
0.86
0.88
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Atossa Therapeutics (ATOS) Moving Averages

Feb 22, 2025, 12:36 AM
Period
Simple
Exponential
MA5
0.83Buy
0.84Buy
MA10
0.82Buy
0.83Buy
MA20
0.85Buy
0.85Buy
MA50
0.95Sell
0.95Sell
MA100
1.17Sell
1.09Sell
MA200
1.26Sell
1.21Sell
Atossa Therapeutics’s (ATOS) 10-Day exponential moving average is 0.83, while Atossa Therapeutics’s (ATOS) share price is $0.84, making it a Buy.
Atossa Therapeutics’s (ATOS) 100-Day exponential moving average is 1.09, while Atossa Therapeutics’s (ATOS) share price is $0.84, making it a Sell.
Atossa Therapeutics’s (ATOS) stock price is $0.84 and Atossa Therapeutics’s (ATOS) 50-day simple moving average is 0.95, creating a Sell signal.
Atossa Therapeutics’s (ATOS) stock price is $0.84 and Atossa Therapeutics’s (ATOS) 100-day simple moving average is 1.17, creating a Sell signal.
Atossa Therapeutics’s (ATOS) stock price is $0.84 and Atossa Therapeutics’s (ATOS) 200-day simple moving average is 1.26, creating a Sell signal.

Atossa Therapeutics (ATOS) Technical Indicators

Feb 22, 2025, 12:36 AM
Name
Value
Implied Action
RSI (14)
51.21
Neutral
STOCH (9,6)
69.80
Neutral
STOCHRSI (14)
65.99
Neutral
MACD (12,26)
-0.03
Sell
ADX (14)
33.42
Neutral
Williams %R
-18.78
Sell
CCI (14)
38.02
Neutral
ATR (14)
0.06
-
Ultimate Oscillator
57.08
Neutral
ROC
3.53
Buy
Atossa Therapeutics’s (ATOS) Relative Strength Index (RSI) is 51.21, creating a Neutral signal.
Atossa Therapeutics’s (ATOS) Trend Strength Indicator (ADX) is 33.42, creating a Neutral signal.
Atossa Therapeutics’s (ATOS) Commodity Channel Index (CCI) is 38.02, creating a Neutral signal.
Atossa Therapeutics’s (ATOS) Price Rate of Change (ROC) is 3.53, creating a Buy signal.

FAQ

Is ATOS a Buy, Hold, or Sell?
Based on ATOS’s technical indicators, ATOS is a Hold.
    What is ATOS’s RSI (14)?
    ATOS’s RSI (14) is 51.21, which suggests ATOS is a Neutral.
      What is ATOS’s MACD?
      ATOS’s MACD is -0.03, which suggests ATOS is a Sell.
        What is ATOS’s 5-day moving average?
        ATOS’s 5-day moving average is 0.83, which suggests ATOS is a Buy.
          What is ATOS’s 20-day moving average?
          ATOS 20-day moving average is 0.85, which suggests ATOS is a Buy.
            What is ATOS’s 50-day moving average?
            ATOS’s 50-day moving average is 0.95, which suggests ATOS is a Sell.
              What is ATOS’s 200-day moving average?
              ATOS’s 200-day moving average is 1.26, which suggests ATOS is a Sell.
                What is ATOS’s Williams % R (14)?
                ATOS’s Williams % R (14) is -18.78, which suggests ATOS is a Sell.
                  What is ATOS’s CCI (14)?
                  ATOS’s CCI (14) is 38.02, which suggests ATOS is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis